Inhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...